Multi-classifier System for Straitifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy

Conditions: Papillary Renal Cell Carcinoma Interventions: Drug: Pembrolizumab; Drug: Placebo Sponsors: First Affiliated Hospital, Sun Yat-Sen University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials